MAGNESIUM
DEFICIT(HYPOMAGNESEMIA)
Hypomagnesemia refers to a below-normal serum magnesium concentration.
The normal serum magnesium level is 1.5 to 2.5 mEq/L (or 1.8–3.0 mg/dL; 0.8–1.2
mmol/L). Approximately one third of serum magnesium is bound to protein; the
remain-ing two thirds exists as free cations (Mg ++). Like calcium, it is the ionized fraction
that is primarily involved in neuromuscular activity and other physiologic
processes. As with calcium levels, magnesium levels should be evaluated in
combination with albu-min levels. Low serum albumin levels decrease total
magnesium.
Hypomagnesemia is a
common yet often overlooked imbalance in acutely and critically ill patients.
It may occur with withdrawal from alcohol and administration of tube feedings
or parenteral nutrition.
An important route for magnesium loss is the GI tract. Loss of magnesium
from the GI tract may occur with nasogastric suc-tion, diarrhea, or fistulas.
Because fluid from the lower GI tract has a higher concentration of magnesium
(10–14 mEq/L) than fluid from the upper tract (1–2 mEq/L), losses from diarrhea
and intestinal fistulas are more likely to induce magnesium deficit than are
those from gastric suction. Although magnesium losses are relatively small in
nasogastric suction, hypomagnesemia will occur if losses are prolonged and magnesium
is not replaced through IV infusion. Because the distal small bowel is the
major site of magnesium absorption, any disruption in small bowel function, as
in intestinal resection or inflammatory bowel disease, can lead to
hypomagnesemia.
Alcoholism is currently the most common cause of sympto-matic
hypomagnesemia in the United States. Hypomagnesemia is particularly troublesome
during treatment of alcohol withdrawal. Therefore, the serum magnesium level
should be measured at least every 2 or 3 days in patients going through
withdrawal from alco-hol. The serum magnesium level may be normal on admission
but fall as a result of metabolic changes, such as the intracellular shift of
magnesium associated with IV glucose administration.
During nutritional repletion, the major cellular electrolytes move from
the serum to newly synthesized cells. Thus, if the en-teral or parenteral
feeding formula is deficient in magnesium con-tent, serious hypomagnesemia will
occur. Because of this, serum magnesium levels should be measured at regular
intervals in pa-tients who are receiving parenteral nutrition and enteral
feedings, especially those who have undergone a period of starvation. Other
causes of hypomagnesemia include the administration of amino-glycosides, cyclosporine,
cisplatin, diuretics, digitalis, and am-photericin and the rapid administration
of citrated blood, especially to patients with renal or hepatic disease.
Magnesium deficiency often occurs in diabetic ketoacidosis, secondary to
increased renal excretion during osmotic diuresis and shifting of magnesium
into the cells with insulin therapy. Other contributing causes are sep-sis,
burns, and hypothermia.
Clinical manifestations of hypomagnesemia are largely confined to the
neuromuscular system. Some of the effects are due directly to the low serum
magnesium level; others are due to secondary changes in potassium and calcium
metabolism. Symptoms do not usually occur until the serum magnesium level is
less than 1 mEq/L (0.5 mmol/L).
Among the neuromuscular changes are hyperexcitability with muscle
weakness, tremors, and athetoid movements (slow, involuntary twisting and
writhing). Others include tetany, gen-eralized tonic-clonic or focal seizures,
laryngeal stridor, and pos-itive Chvostek’s and Trousseau’s signs, which occur,
in part, because of accompanying hypocalcemia.
Magnesium deficiency can disturb the ECG by prolonging the QRS,
depressing the ST segment, and predisposing to cardiac dys-rhythmias, such as
premature ventricular contractions, supra-ventricular tachycardia, torsades de
pointes (a form of ventricular tachycardia), and ventricular fibrillation.
Increased susceptibility to digitalis toxicity is associated with low serum
magnesium lev-els. This is important because patients receiving digoxin are
also likely to be receiving diuretic therapy, predisposing them to renal loss
of magnesium.
Hypomagnesemia may be
accompanied by marked alterations in mood. Apathy, depression, apprehension,
and extreme agita-tion have been noted, as well as ataxia, dizziness, insomnia,
and confusion. At times, delirium, auditory or visual hallucinations, and frank
psychoses may occur.
On laboratory analysis, the serum magnesium level is less than 1.5 mEq/L
or 1.8 mg/dL (0.75 mmol/L). Hypomagnesemia is frequently associated with
hypokalemia and hypocalcemia. About 25% of magnesium is protein-bound,
principally to al-bumin. A decreased serum albumin level can, therefore, reduce
the measured total magnesium concentration; however, it does not reduce the
ionized plasma magnesium concentration. ECG evaluations reflect magnesium,
calcium, and potassium deficien-cies, tachydysrhythmias, prolonged PR and QT
intervals, wide-ning QRS, ST segment depression, flattened T waves, and a
prominent U wave. Torsades de pointes is associated with a low magnesium level.
Premature ventricular contractions, parox-ysmal atrial tachycardia, and heart
block may also occur. Uri-nary magnesium levels may be helpful in identifying
causes of magnesium depletion and are measured after a loading dose of
magnesium sulfate is administered. Two newer diagnostic tech-niques (nuclear
magnetic resonance spectroscopy and the ion selective electrode) are sensitive
and direct means to measure ionized serum magnesium levels.
Mild magnesium deficiency can be corrected by diet alone. Prin-cipal
dietary sources of magnesium are green leafy vegetables, nuts, legumes, whole
grains, and seafood. Magnesium is also plentiful in peanut butter and
chocolate. When necessary, magnesium salts can be administered orally to
replace continuous excessive losses. Diarrhea is a common complication of
excessive ingestion of mag-nesium. Patients receiving parenteral nutrition
require magnesium in the IV solution to prevent hypomagnesemia. IV
administrationof
magnesium sulfate must be given by an infusion pump and at a rate not to exceed
150 mg/min. A bolus dose of magnesium sul-fate given too rapidly can produce
cardiac arrest. Vital signs must be assessed frequently during magnesium
administration to detect changes in cardiac rate or rhythm, hypotension, and
respiratory distress. Monitoring urine output is essential before, during, and
after magnesium administration; the physician is notified if urine volume decreases
to less than 100 mL over 4 hours. Calcium glu-conate must be readily available
to treat hypocalcemic tetany or hypermagnesemia.
Overt symptoms of hypomagnesemia are treated with paren-teral
administration of magnesium. Magnesium sulfate is the most commonly used
magnesium salt. Serial magnesium concentra-tions can be used to regulate the
dosage.
The nurse should be aware of patients at risk for hypomagne-semia and
observe for its signs and symptoms. Patients receiving digitalis are monitored
closely because a deficit of magnesium can predispose them to digitalis
toxicity. When hypomagnesemia is severe, seizure precautions are implemented.
Other safety pre-cautions are instituted, as indicated, if confusion is
observed.
Because difficulty in
swallowing (dysphagia) may occur in magnesium-depleted patients, the ability to
swallow should be tested with water before oral medications or foods are
offered. Dysphagia is probably related to the athetoid or choreiform (rapid,
involuntary, and irregular jerking) movements asso-ciated with magnesium
deficit. To determine neuromuscular irritability, the nurse needs to assess and
grade deep tendon re-flexes.
Teaching plays a major role in treating magnesium deficit, particularly
that resulting from abuse of diuretic or laxative med-ications. In such cases,
the nurse can instruct the patient about the need to consume magnesium-rich
foods. For patients experi-encing hypomagnesemia from abuse of alcohol, the
nurse can provide teaching, counseling, support, and possible referral to
alcohol abstinence programs or other professional help.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.